An ancient empire hiding in plain sight, and the billion-dollar cost of illegal fishing
This week on the podcast, Contributing Correspondent Lizzie Wade joins host Sarah Crespi to discuss a turning point for one ancient Mesoamerican city: Tikal. On 16 January 378 C.E., the Maya city lost its leader and the replacement may have been a stranger. We know from writings that the new leader wore the garb of another culture—the Teotihuacan—who lived in a giant city 1000 kilometers away. But was this new ruler of a Maya city really from a separate culture? New techniques being used at the Tikal and Teotihuacan sites have revealed conflicting evidence as to whether Teotihuacan really held sway over a much larger r...
Source: Science Magazine Podcast - February 27, 2020 Category: Science Authors: Science Magazine Source Type: podcasts
An ancient empire hiding in plain sight, and the billion-dollar cost of illegal fishing
This week on the podcast, Contributing Correspondent Lizzie Wade joins host Sarah Crespi to discuss a turning point for one ancient Mesoamerican city: Tikal. On 16 January 378 C.E., the Maya city lost its leader and the replacement may have been a stranger. We know from writings that the new leader wore the garb of another culture—the Teotihuacan—who lived in a giant city 1000 kilometers away. But was this new ruler of a Maya city really from a separate culture? New techniques being used at the Tikal and Teotihuacan sites have revealed conflicting evidence as to whether Teotihuacan really held sway over a much ...
Source: Science Magazine Podcast - February 27, 2020 Category: Science Authors: Science Magazine Source Type: podcasts
An ancient empire hiding in plain sight, and the billion-dollar cost of illegal fishing
This week on the podcast, Contributing Correspondent Lizzie Wade joins host Sarah Crespi to discuss a turning point for one ancient Mesoamerican city: Tikal. On 16 January 378 C.E., the Maya city lost its leader and the replacement may have been a stranger. We know from writings that the new leader wore the garb of another culture —the Teotihuacan—who lived in a giant city 1000 kilometers away. But was this new ruler of a Maya city really from a separate culture? New techniques being used at the Tikal and Teotihuacan sites have revealed conflicting evidence as to whether Teotihuacan really held sway over a much larger ...
Source: Science Magazine Podcast - February 27, 2020 Category: Science Authors: Science Tags: Scientific Community Source Type: podcasts
An ancient empire hiding in plain sight, and the billion-dollar cost of illegal fishing
This week on the podcast, Contributing Correspondent Lizzie Wade joins host Sarah Crespi to discuss a turning point for one ancient Mesoamerican city: Tikal. On 16 January 378 C.E., the Maya city lost its leader and the replacement may have been a stranger. We know from writings that the new leader wore the garb of another culture —the Teotihuacan—who lived in a giant city 1000 kilometers away. But was this new ruler of a Maya city really from a separate culture? New techniques being used at the Tikal and Teotihuacan sites have revealed conflicting evidence as to whether Teotihuacan really held sway over a much larger ...
Source: Science Magazine Podcast - February 24, 2020 Category: Science Authors: Science Tags: Scientific Community Source Type: podcasts
Surviving childhood cancer treatment
In a British cohort, 30% of patients who had survived childhood cancer had died within 45 years of diagnosis; only 6% were expected to have died.
51% had developed a new primary cancer, but a 26% died of cardiovascular disease - thought to be caused by their treatment. Consequently, efforts to reduce long term mortality have focused on reducing... (Source: The BMJ Podcast)
Source: The BMJ Podcast - January 21, 2020 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
Surviving childhood cancer treatment
In a British cohort, 30% of patients who had survived childhood cancer had died within 45 years of diagnosis; only 6% were expected to have died.
51% had developed a new primary cancer, but a 26% died of cardiovascular disease - thought to be caused by their treatment. Consequently, efforts to reduce long term mortality have focused on reducing exposure to the most toxic aspects of anticancer treatment, including radiotherapy.
In this pod cast we’re joined by Daniel Mulrooney, associate professor in the Division of Cancer Survivorship, at St Jude Children’s Research Hospital and one of the authors of the paper Major...
Source: The BMJ Podcast - January 21, 2020 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
Surviving childhood cancer treatment
In a British cohort, 30% of patients who had survived childhood cancer had died within 45 years of diagnosis; only 6% were expected to have died.
51% had developed a new primary cancer, but a 26% died of cardiovascular disease - thought to be caused by their treatment. Consequently, efforts to reduce long term mortality have focused on reducing exposure to the most toxic aspects of anticancer treatment, including radiotherapy.
In this podcast we’re joined by Daniel Mulrooney, associate professor in the Division of Cancer Survivorship, at St Jude Children’s Research Hospital and one of the authors of the paper Major ...
Source: The BMJ Podcast - January 21, 2020 Category: General Medicine Authors: BMJ Group Source Type: podcasts
Researchers flouting clinical reporting rules, and linking gut microbes to heart disease and diabetes
Though a U.S. law requiring clinical trial results reporting has been on the books for decades, many researchers have been slow to comply. Now, 2 years after the law was sharpened with higher penalties for noncompliance, investigative correspondent Charles Piller took a look at the results. He talks with host Sarah Crespi about the investigation and a surprising lack of compliance and enforcement.
Also this week, Sarah talks with Brett Finlay, a microbiologist at the University Of British Columbia, Vancouver, about an Insight in this week’s issue that aims to connect the dots between noncommunicable diseases like heart...
Source: Science Magazine Podcast - January 16, 2020 Category: Science Authors: Science Magazine Source Type: podcasts
Researchers flouting clinical reporting rules, and linking gut microbes to heart disease and diabetes
Though a U.S. law requiring clinical trial results reporting has been on the books for decades, many researchers have been slow to comply. Now, 2 years after the law was sharpened with higher penalties for noncompliance, investigative correspondent Charles Piller took a look at the results. He talks with host Sarah Crespi about the investigation and a surprising lack of compliance and enforcement.
Also this week, Sarah talks with Brett Finlay, a microbiologist at the University Of British Columbia, Vancouver, about an Insight in this week’s issue that aims to connect the dots between noncommunicable diseases li...
Source: Science Magazine Podcast - January 16, 2020 Category: Science Authors: Science Magazine Source Type: podcasts
Researchers flouting clinical reporting rules, and linking gut microbes to heart disease and diabetes
Though a law requiring clinical trial results reporting has been on the books for decades, many researchers have been slow to comply. Now, 2 years after the law was sharpened with higher penalties for noncompliance, investigative correspondent Charles Piller took a look at the results. He talks with host Sarah Crespi about the investigation and a surprising lack of compliance and enforcement. Also this week, Sarah talks with Brett Finlay, a microbiologist at the University Of British Columbia, Vancouver, about an Insight in this week ’s issue that aims to connect the dots between noncommunicable diseases like heart disea...
Source: Science Magazine Podcast - January 16, 2020 Category: Science Authors: Science Tags: Scientific Community Source Type: podcasts
Researchers flouting clinical reporting rules, and linking gut microbes to heart disease and diabetes
Though a law requiring clinical trial results reporting has been on the books for decades, many researchers have been slow to comply. Now, 2 years after the law was sharpened with higher penalties for noncompliance, investigative correspondent Charles Piller took a look at the results. He talks with host Sarah Crespi about the investigation and a surprising lack of compliance and enforcement.
Also this week, Sarah talks with Brett Finlay, a microbiologist at the University Of British Columbia, Vancouver, about an Insight in this week’s issue that aims to connect the dots between noncommunicable diseases like heart dise...
Source: Science Magazine Podcast - January 10, 2020 Category: Science Authors: Science Tags: Scientific Community Source Type: podcasts
Ancestry DNA tests can over or under estimate genetic disease risk
Direct-to-consumer genetic tests are sold online and in shops as a way to “find out what your DNA says".
They insights into ancestry or disease risks; others claim to provide information on personality, athletic ability, and child talent. However, interpretation of genetic data is complex and context dependent, and DTC genetic tests may produce false positive and fals e negative results.
Rachel Horton, clinical training fellow, Anneke Lucassen, chair of British Society of Genetic Medicine, and Jude Hayward the RCGP clinical champion for genomics join us to discuss how this deluge of genetic data is affecting patients,...
Source: The BMJ Podcast - October 17, 2019 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
Ancestry DNA tests can over or under estimate genetic disease risk
Direct-to-consumer genetic tests are sold online and in shops as a way to “find out what your DNA says".
They insights into ancestry or disease risks; others claim to provide information on personality, athletic ability, and child talent. However, interpretation of genetic data is complex and context dependent, and DTC genetic tests may produce false positive and false negative results.
Rachel Horton, clinical training fellow, Anneke Lucassen, chair of British Society of Genetic Medicine, and Jude Hayward the RCGP clinical champion for genomics join us to discuss how this deluge of genetic data is affecting patients, ...
Source: The BMJ Podcast - October 17, 2019 Category: General Medicine Authors: BMJ Group Source Type: podcasts
Brexit - Planning for medicine shortages
This week we saw the release of the much awaited Yellowhammer documents from the government, documents which outline some of the risks involved with Britain ’s sudden departure from the EU. The documents themselves outline that there are risks to the supply of medicines - but do not set out the detail of how those risks have been mitigated, and what doctors and patients should do to plan for the possibility.In this podcast we hear from Andrew Goddard , president of the Royal College of Physicians, and Sandra Gidley, president of the Royal Pharmaceutical Society. We also have a statement from the Royal College of Radiolog...
Source: The BMJ Podcast - September 13, 2019 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
Brexit - Planning for medicine shortages
This week we saw the release of the much awaited Yellowhammer documents from the government, documents which outline some of the risks involved with Britain ’s sudden departure from the EU. The documents themselves outline that there are risks to the supply of medicines - but do not set out the detail of how those risks have been mitigated, and... (Source: The BMJ Podcast)
Source: The BMJ Podcast - September 13, 2019 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
